Study Stopped
This clinical trial has been terminated。
Detection of Enterovirus Genotypes by CRISPR Technology
Rapid Identification and Clinical Transformation of Various Enterovirus Genotypes Based on CRISPR Technology
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
CRISPR-enterovirus detection system was constructed in this study for detection variety genotypes of enterovirus rapidly in children suspected or diagnosed as enterovirus infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2020
CompletedFirst Posted
Study publicly available on registry
September 2, 2020
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJune 9, 2023
June 1, 2023
1.3 years
August 25, 2020
June 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Successful construction of CRISPR-enterovirus detection system
It is a binary variable ("yes/no").If the system meet all the following criteria, it would be setted into "yes" .According to the results of CRISPR-enterovirus detection system and the comparison method: 1. the positive coincidence rate and negative coincidence rate are both over 95.0%; 2. the value of Kappa using to express the consistency of those two methods is over 0.75; 3. the sensitivity and specificity of the CRISPR-enterovirus detection system for detection of enterovirus are over 90.0% and 95.0%; 4. the coefficient of variation between batches is less 15.0%, and each batch detection takes less than 1 hour.
At enrollment
Interventions
This study was a laboratory diagnostic study without any intervention.
Eligibility Criteria
Patients who came to the Children's Hospital of Fudan University and were diagnosed with enterovirus infection.
You may qualify if:
- Patients with clinically suspected or confirmed enterovirus infection
You may not qualify if:
- Patients with clinical diagnosis of non-enterovirus infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Samples of feces, blood and cerebrospinal fluid (the remainder of routine testing samples) from 500 children with suspected or confirmed enterovirus infection were collected for detection by the CRISPR technique.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Liling Qian
Children's Hospital of Fudan University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2020
First Posted
September 2, 2020
Study Start
April 1, 2023
Primary Completion
August 1, 2024
Study Completion
September 1, 2024
Last Updated
June 9, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share